@FiercePharma: Final Four coach did time as pharma sales rep. Article | Follow @FiercePharma
> The U.K.'s National Health Service risks losing millions of pounds after a European legal opinion that calls for a ban on the growing practice of paying doctors to persuade them to prescribe cheaper generic medicines. Report
> Sanofi-Aventis has settled patent infringement suits with three more generic drugmakers over its cancer drug Eloxatin, putting off their copycat versions till August 2012. Report
> For the second time in six months, Merck is going to court to defend its patents for Cancidas, an intravenous drug that treats life-threatening fungal infections, against generic competitors. Report
> The FDA approved a reformulated version of the powerful painkiller OxyContin that is designed to make it harder to tamper with the product. Release | Report
> Many children starting treatment with atypical antipsychotics don't get the recommended glucose and lipid screening, an Archives of Pediatric and Adolescent Medicine study found. Report
> Dishman Pharmaceuticals & Chemicals, an Indian drugmaker, plans to raise 750 million rupees ($17 million) next month selling non-convertible bonds to build new plants, Managing Director J.R. Vyas said. Report
> The Drug Controller General of India has asked Dr Reddy's Laboratories to provide details about its relationships with doctors in the wake of revised conflicts-of-interest guidelines from the Medical Council of India. Report
> A growing number of overdoses of legal opioids, sedatives and tranquilizers led to a 65 percent increase in hospitalizations over seven years. Report
Biotech News
@FierceBiotech: Florida city carves out 1-square-mile biotech hub. Article | Follow @FierceBiotech
@JohnCFierce: Biotech Deal Activity Takes a Breather. It's been too quiet on that front. I hate dull. Report | Follow @JohnCFierce
> Tengion braves a chilly market with $41 million IPO. Article
> Is ailing Antisoma a prime new takeover target? Item
> GSK, Crucell join R&D forces on new malaria vaccine. Story
> A blockbuster FDA deadline looms and Dendreon shares turn red-hot. Report
Manufacturing News
> MIT's Hockfield: "Time to get busy reinventing manufacturing." Report
> Chinese regulator faces bribery charge in vaccine scandal. Story
> Perrigo loses $400,000 in drug shipment theft. Item
> Report: Add REMS to Sentinel System. Story
Biotech Research News
> Explosion of cancer drug trials spurs a new approach. Story
> Researchers find "weak link" in Alzheimer's therapies. Report
> A research team in the U.K. is proposing that a new group of synthetic molecules could play a lead role fighting cancer, inflammation and other diseases. Story
> Lab breakthrough opens door to new generation of antibiotics. Item
> Genetics research pointing to new longevity drug pathways. Article
And Finally... Demand for prescription assistance in the U.S. has increased sharply following the 2008 economic crisis. Report